On the basis of the potential role of RAGE in adipogenesis, inflammation, and insulin resistance [5–8], we explored whether its expression in EAT was associated with EAT adiposity and the metabolic dysfunctions, such as impaired insulin signaling, normally found in CAD patients. Here, INS is linked to coronary artery disorder.